🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
The purpose of this study is to determine whether ABI-009 will make advance...
Status
Terminated
Location
Ochsner Clinic Foundation
Start Date
2018-11-05
Trial ID
NCT03670030
Treatments Being Tested
This study adopts multicenter/randomized trial design. It plans to enroll p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-30
Trial ID
NCT06941142
Treatments Being Tested
This is a phase 1, multi-center, open-label, dose-escalation study of nab-s...
Status
Recruiting
Location
South Texas Accelerated Research Therapeutics, LLC
Start Date
2022-11-23
Trial ID
NCT05661461
Treatments Being Tested
This study adopts a multi-center, open-label, non-randomized trial design. ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-11-13
Trial ID
NCT07241936
Treatments Being Tested
Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-04-09
Trial ID
NCT02009332
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
Rapamycin is a drug that has been approved by the Food and Drug Administrat...
Status
Terminated
Location
Yale Comprehensive Cancer Center at Yale University School of Medicine
Start Date
2006-02
Trial ID
NCT00337376
A randomized, double-blind, multicenter phase III clinical study to evaluat...
Status
Not Yet Recruiting
Location
Clinical Trials Information Group
Start Date
2025-04
Trial ID
NCT06929325
This phase I trial studies the side effects and best dose of nanoparticle a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-08-15
Trial ID
NCT02975882